Carisma Therapeutics Inc. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Carisma Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q1 2024.
  • Carisma Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.46M, a 1.04% increase year-over-year.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2023 was $5.76M, a 21.3% increase from 2022.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2022 was $4.75M.
  • Carisma Therapeutics Inc. annual Operating Lease, Payments for 2021 was $0.000.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.46M +$15K +1.04% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $1.45M +$987K +214% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $461K +$418K +972% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $43K +$5K +13.2% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q1 2020 $38K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $38K +$38K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.